Ipilimumab vs Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid

## Ipilimumab vs Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid — N/A.

## Chemical Properties

**Type**: Ipilimumab — Antibody; Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid — Vaccine component.